Inmune Bio INMB
NASDAQ INMB
$1.62 +0.01 (+0.94%)
As of: Oct 21, 2026 · 11:37 AM EDT

Inmune Bio (INMB) Common Stock Issued (2018 - 2025)

Updated

Analysis

Inmune Bio (INMB) Common Stock Issued (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 6.00 Mn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Inmune Bio 43.15 Mn -49.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 22.27 Mn
Mar 31, 2025 5.27 Mn
Dec 31, 2024 422,000.00
Sep 30, 2024 12.29 Mn
Jun 30, 2022 699,000.00
Mar 31, 2022 30,000.00
Sep 30, 2021 1.14 Mn
Mar 31, 2021 18,000.00
Sep 30, 2020 23.24 Mn
Jun 30, 2020 664,000.00
Mar 31, 2020 1.00 Mn
Jun 30, 2019 4.96 Mn
Mar 31, 2019 7.25 Mn
Mar 31, 2018 900,000.00
API Access

Inmune Bio Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INMB&period=max&api_key=YOUR_API_KEY